Eligibility
Children enrolled in or eligible for the state's Medicaid program belong to this eligibility category.
Medicaid-eligible children or Medi-Cal-eligible children
Temperatures must be documented this many times each workday.
Twice (AM & PM)
A VIS must be provided at this time.
before administering the vaccine
MMR, Varicella, and MMRV vaccines may be administered by this route/s.
subcutaneous (SQ) or intramuscular (IM)
This group includes children who have no health insurance coverage.
Uninsured children
This program provides vaccines at no cost to eligible children through age 18.
Vaccines for Children (VFC) Program
A VIS can be provided in these two formats.
Paper & Electronic
This practice is discouraged because it increases the risk of vaccine errors and waste.
Predrawing Vaccines
This Indigenous group primarily lives in Alaska.
Alaska Natives
Provider of Record for East Valley Pediatrics
This document explains the benefits and risks of a vaccine before it is given.
Vaccine Information Statement (VIS)
This must be documented before administering a vaccine and is the first question in the MAR.
VFC eligibility
This Indigenous group primarily lives in the continental U.S.
American Indians
This occurs when vaccine storage temperatures go above or below the recommended range.
Temperature Excursion
The date given and this VIS-related date must be recorded in the medical record.
VIS date or VIS edition
If a patient receives the RSV preventive antibody Beyfortus (nirsevimab) WITH any vaccines given at the same visit and experiences an adverse event, reports should be submitted to this FDA safety reporting program.
Vaccine Adverse Event Reporting System (VAERS)
Children whose has insurance but does not cover vaccines.
Underinsured
This screening must be completed at every immunization visit.
VFC eligibility screening
This document explains the benefits and risks of preventive antibody injections, such as Beyfortus.
Immunization Information Statement (IIS)
If a patient receives the RSV preventive antibody Beyfortus (nirsevimab) WITHOUT any vaccines given at the same visit and experiences an adverse event, reports should be submitted to this FDA safety reporting program.
MedWatch